According to a market report by Lucintel, the future of the global mutation screening library market looks promising with opportunities in the disease research and drug development markets. The global mutation screening library market is expected to grow with a CAGR of 4.5% from 2025 to 2031. The major drivers for this market are the rising adoption in academic & biotech research institution, the increasing collaboration between research center & industry, and the growing focus on drug target validation & optimization using mutation library.
A more
than 150-page report to understand trends, opportunity and forecast in global
mutation screening library market to 2031 by type (random mutagenesis library
and site-directed mutagenesis library), application (disease research, drug
development, and others), and region (North America, Europe, Asia Pacific, and
the Rest of the World).
Lucintel
forecasts that, within the type category, random mutagenesis library is
expected to witness higher growth over the forecast period.
Within the
application category, disease research is expected to witness higher growth.
Download
sample by clicking on mutation
screening library market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
VectorBuilder
Inc., BioIVT, GenScript, Abace-biology, Bio-Synthesis are the major suppliers
in the mutation screening
library market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment